MeadWestvaco Corp. purchases medical packaging company
- June 6, 2012
Paper and packaging company MeadWestvaco Corp. announced Wednesday it had purchased a Swedish company specializing in the electronic monitoring of patient adherence in clinical drug trials.
AARDEX Group SA was founded by scientists Dr. Bernrd Vrijens and Dr. John Urquhart, who pioneered electronic medication monitoring. In their packaging solutions, a small microcircuit is integrated into drug packages, which records the time and date of each time the packet is opened. The technology has been used in more than 500 clinical research studies that have included more than 500,000 trial participants.
“We recognize the critical global need to create packaging solutions that address the issue of medication non-adherence,” Bruce Thomas, president, MWV Healthecare and senior vice president, global innovation, said in a statement. “With the acquisition of AARDEX Group, MWV will now be able to provide customers with a complete range of packaging, data analysis and service solutions that address non-adherence to medications, from phase II clinical trials all the way through commercialization.”
With the acquisition of AARDEX Group, MWV adds the Medication Event Monitoring Systems (MEMS) Cap for bottles to its portfolio of adherence-enhancing package designs.
The AARDEX Group management team will remain in place and its 12 employees will become MWV employees.